Ekso Bionics (EKSO) announced a 1-for-15 reverse stock split of common shares, effective May 27.
The split will reduce the number of outstanding shares to 2.35 million from almost 35.3 million, the company said Monday in a statement.
Shares of the company fell 26% in after-hours trading.